Exposure of isolated arteries to oxidatively modified low density lipoprotein (LDL) has been reported to suppress endothelium-dependent relaxation (EDR). To determine whether lipid degradation products in oxidized LDL contribute to impaired relaxation, we have tested the responsiveness of isolated rabbit aortas to endothelium-dependent relaxants (acetylcholine, ATP, and calcium ionophore A23187) and nitroglycerin before and after 2-hour incubations with selected lipids and LDL preparations. Concentrations (10 ,M) of lecithin, phosphatidylserine, lysophosphatidylserine, sphingomyelin, phosphatidic acid, palmitate, arachidonate, and auto-oxidized arachidonate had no effect on EDR. Concentrations (10 ,uM) of lysolecithin, lyso-platelet activating factor, and sphingosine significantly suppressed endotheliumdependent relaxation. Native LDL (100 ,ug/ml incubation buffer) containing only small amounts of lysophosphatidylcholine exerted no effect on EDR. In contrast, LDL preparations oxidatively modified by exposure to cultured endothelial cells or copper inhibited EDR. When modified LDL was depleted of its lysolecithin by treatment with a selective phospholipase B (lysolecithinase), the inhibitory effects were attenuated. In contrast, native LDL accumulating lysolecithin under the influence of a phospholipase A2 (lecithinase) exerted inhibitory effects mimicking those of oxidized LDL. Lipids and lipoproteins had no effect on the responsiveness to nitroglycerin, an endothelium-independent vasodilator. We conclude that lysolecithin in oxidatively modified LDL contributes importantly to its vasomotor effects. (Circulation Research 1993;72:161-166 
P revious reports indicate that human low density lipoprotein (LDL) exposed to endothelial cells in culture or to transition metals undergoes a peroxidative degradation that confers cytotoxic properties to the lipoprotein. [1] [2] [3] [4] Of interest is that isolated arteries incubated with preparations of oxidized LDL (O-LDL) become insensitive to endothelium-dependent vasodilators and acquire vasomotor properties resembling those of atherosclerotic arteries. 5 Parthasarathy et al67 have demonstrated that oxidative modification of LDL is associated with a substantial degradation of lecithin to lysolecithin, a reaction mediated by a phospholipase A2 activity apparently closely associated with apolipoprotein B-100. Recently, we have observed that membrane-active effects of O-LDL were markedly attenuated after depletion of its lysolecithin by pretreatment with albumin, a potent lysolecithin scavenger.8 In addition, incubation of arteries with submicellar concentrations of palmitoyl lysolecithin produced changes in arterial reactivity mimicking those evoked by O-LDL. 5 Although absorption of O-LDL with albumin is very effective in removing lysolecithin, the possibility must be considered that this procedure concomitantly extracts other lipids that might contribute to the activity of O-LDL. Although a report by Yokoyama et a19 appeared to confirm the importance of lysolecithin in mediating vasoactive effects of O-LDL, others found that free and lipoprotein-bound lysolecithin had no or variable effects on endothelium-dependent arterial relaxation.10"'1 Others concluded that both native LDL (N-LDL) and O-LDL exerted their effects by inactivating endothelium-derived relaxing factor. '2 Therefore, mechanisms of action of LDL on vasomotor regulation remain controversial.
In the present study, we have tested effects of N-LDL and O-LDL containing varying amounts of lysolecithin after pretreatment with phospholipase A2 (lecithinase) or phospholipase B (lysolecithinase). In addition, we have determined the vasomotor effects of nonlysolecithin lipids that may be contained in O-LDL.
Materials and Methods
Artery Preparation
Pharmacological experiments with isolated rabbit arterial strips were performed as previously described. 5, 13 Male New Zealand White rabbits were anesthetized with pentobarbital (30 mg/kg i.v.), and the descending aorta was rapidly excised and placed in Krebs-Henseleit buffer of the following composition (mM): NaCI 116, KCl 4.0, NaHCO3 25, CaCl2 1.5, MgSO4 1.2, NaH2PO4 1.2, glucose 5.0, and Na4 EDTA 0.025 (25 ,uM 
Data Analysis
Relaxation responses were expressed as a percentage of stable constrictor tone developed in response to phenylephrine.5'3 Differences between group means before and after incubations with lipids/lipoproteins were analyzed by the Wilcoxon signed rank test for paired observations. Values of p<O0.05 were defined as statistically significant.
Results

Effects of Phospholipids
Two-hour incubations with 10-MM concentrations of lecithin, phosphatidylserine, sphingomyelin, lysophosphatidylserine, and phosphatidic acid had no effect on endothelium-dependent relaxation (Table 1) . This indicates that not all phospholipid amphiphile with detergent effects impairs endothelium-dependent relaxation. Attempts at testing platelet activating factor at concentrations of 1-10 jLtM were not possible because of the instability (insolubility) of this phospholipid in Krebs' buffer. Incubations with 10-,M concentrations of lysolecithin, lyso-platelet activating factor, and sphingosine exerted similar inhibitory effects on endothelium-dependent relaxation (Table 2) . Incubations with 1 .M lysolecithin, lyso-platelet activating factor, and sphingosine produced only modest suppressions in the response to acetylcholine. Lysolecithin (1 ,uM) had a minor effect on the response to ATP. None of the lysolipids produced significant effects at concentrations < 1 ,M. Incubations with phospholipids (10 ,uM) arachidonate (exposure of 10 ,tM arachidonate to an oxygenated EDTA-free buffer for 24 hours at 37°C) did not significantly affect the responsiveness to endothelium-dependent vasodilators.
Lecithin and Lysolecithin Contents of Modified LDLs
The lecithin and lysolecithin contents of N-LDL, O-LDL, N-LDL treated with phospholipase A2, and O-LDL treated with phospholipase B are shown in Table 4 .
Effects of Modified LDLs
Incubations with N-LDL had no effect on subsequent relaxation responses. In contrast, after pretreatment with phospholipase A2, a procedure that degraded a substantial fraction of the lipoprotein lecithin to its lysoform, the enzymatically modified lipoprotein evoked a marked unresponsiveness to acetylcholine. Unreisolated O-LDL was as potent as phospholipase A2-treated N-LDL in inhibiting relaxations. When lysolecithin in O-LDL was degraded to approximately one third of its original value, the lipoprotein's inhibitory effects were attenuated (Table 5) . Lipoprotein-free incubation mixtures had no effect on endotheliumdependent relaxations (Table 5 , figures in parentheses). 
Relation Between LDL-Phospholipid and Endothelium-Dependent Relaxation
The relations between lysolecithin in various LDL preparations and endothelium-dependent relaxation after exposure of arteries to these LDLs are depicted in Figure 1 . The graph suggests that increasing lysolecithin contents are associated with increasing impairment in cholinergic relaxation. Arteries were incubated for 2 hours with buffer containing LDL preparations (100 ,ug protein/ml). Numbers in parentheses correspond to LDL-free incubation media subjected to the same preparative procedures as the media containing LDL.
* (Figure 1 ). The action of lysolecithin on endothelium-dependent relaxation was, however, not specific, since both sphingosine and lyso-platelet activating factor produced similar changes in cholinergic responsiveness. Compared with lysolecithin, these compounds are present in only very small amounts in oxidatively modified LDL (attempts at demonstrating these compounds in our preparations of LDL were unsuccessful [results not shown]). Of greater importance are hydrolytic products generated from abundant phospholipids other than lysolecithin. Interestingly, lysophosphatidylserine, an aminophospholipid that occurs physiologically predominantly in the inner leaflets of surface membranes, exerted no apparent inhibitory effects on endothelium-dependent relaxation. Yokoyama et al,9 who observed inhibitory effects of copper-oxidized LDL on endothelium-dependent relaxation, extracted the lipoprotein lipids and separated lysolecithin from the rest of the extracts. Whereas separated lysolecithin was active, the nonlysolecithin fraction was inactive. These results appear to corroborate our findings. We have previously proposed that atherosclerotic arteries13 or arteries exposed to O-LDL in vitro5 respond abnormally to endothelium-dependent agonists because of an impaired membrane-delimited regulation. In the present study, micromolar concentrations of phospholipids that affected responsiveness to acetylcholine and ATP did not attenuate responses to A23187 (Table 2 ). This relative preservation of the responsiveness to the ionophore, an agonist that bypasses membrane regulation, is consistent with the hypothesis that phospholipids influence transmembrane signaling. 26 Although lysolecithin in our experiments can account for vasoactive effects of oxidatively modified lipoproteins, they do not rule out other possible molecular mechanisms of action. One major difficulty is that peroxidation produces a multiplicity of lipid peroxidation and hydrolysis products that may be lost during preparative manipulations of the lipoproteins. As shown in Table 4 , it is, for instance, not possible to reisolate ultracentrifugally O-LDL without concomitantly losing some polar lipids (lysolecithin). Nevertheless, two independent interventions depleting LDLs of lysolecithin (absorption with albumin5 and treatment with lysophospholipase B) exerted similar effects, and synthetic lysolecithin substituted with a saturated fatty acid mimicked the effects of O-LDL. On the other hand, exposure to arachidonate (authentic or oxidized) appeared to exert little effects. This study was not designed to determine mechanisms by which polar lipids (lysolecithin) may be transferred from O-LDL to endothelial cells. Although polar lipids are transferred from donors (LDL) to acceptors (endothelial cell membrane) independent of donor/acceptor collision events,27 we cannot rule out the possibility that binding and/or internalization via receptor mechanisms (LDL [apolipoproteins B and E] or scavenger receptors) contribute to amphiphile transfer.
Lysolecithin effects could play an important role in vivo, since the concentration of this lipid in atherosclerotic arterial walls may be increased severalfold compared with that found in normal arteries.28,29 Because lysolecithin in high concentrations is cytotoxic, it may contribute to cell death occurring in atheromatous lesions.30
